Passage Bio, Inc. announced that on March 1, 2024 (the "Effective Date"), Kathleen Borthwick, the Company?s current Senior Vice President and Interim Chief Financial Officer was appointed to serve as Chief Financial Officer. In this role, Ms. Borthwick will continue to serve as the Company?s Principal Financial Officer and Principal Accounting Officer. Ms. Borthwick, age 48, has served as the Company?s Senior Vice President and Chief Financial Officer since the Effective Date.

From July 2023 to February 2024, Ms. Borthwick served as Senior Vice President and Interim Chief Financial Officer. Prior to that, from November 2021 to July 2023, Ms. Borthwick served as Vice President of Finance. From June 1997 to October 2021, Ms. Borthwick served in various leadership roles of increasing responsibility at Johnson & Johnson.

During her tenure at Johnson & Johnson, she worked in Finance in support of Research & Development, Manufacturing, Business Development, Treasury and commercial operations for global Pharmaceutical and Medical Technology business segments. Ms. Borthwick earned her B.S. in Economics with concentrations in Accounting and Health Care Management at the Wharton School of University of Pennsylvania, and her M.B.A. from the Tuck School of Business at Dartmouth College.